| scholarly article | Q13442814 |
| P50 | author | Lily Li | Q53779200 |
| Tadashi Yamamoto | Q123761238 | ||
| P2093 | author name string | K B Bacon | |
| D A Thompson | |||
| S Chen | |||
| L Feng | |||
| D Lo | |||
| J K Harrison | |||
| Y Xia | |||
| G E Garcia | |||
| M A Siani | |||
| P2860 | cites work | Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion | Q24311291 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation | Q28240071 | ||
| A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
| RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis | Q28307643 | ||
| Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia | Q28573077 | ||
| Synthesis of proteins by native chemical ligation | Q29616750 | ||
| Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
| Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody | Q35552490 | ||
| Blocking chemokine receptors | Q36380770 | ||
| Chemokines, leukocyte trafficking, and inflammation | Q40502969 | ||
| Chemokines and tissue injury | Q40543142 | ||
| Chemokine receptors and molecular mimicry | Q40693177 | ||
| Selectivity and antagonism of chemokine receptors | Q40943438 | ||
| Chemokines: progress toward identifying molecular targets for therapeutic agents | Q41068981 | ||
| Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines | Q41088030 | ||
| A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. | Q41091668 | ||
| Plagiarism of the host immune system: lessons about chemokine immunology from viruses. | Q41678908 | ||
| Isolation and characterization of inflammatory leukocytes from glomeruli in an in situ model of glomerulonephritis in the rat. | Q42738361 | ||
| Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid | Q42848458 | ||
| Alternative splicing of the NC1 domain of the human alpha 3(IV) collagen gene. Differential expression of mRNA transcripts that predict three protein variants with distinct carboxyl regions. | Q46039310 | ||
| Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats | Q68013695 | ||
| Use of Blocking Antibodies as Probes for in Vivo Functions of Chemokines | Q71544701 | ||
| Activation of dual T cell signaling pathways by the chemokine RANTES | Q71768178 | ||
| Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats | Q73502014 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glomerulonephritis | Q605006 |
| P304 | page(s) | 193-198 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. | |
| P478 | volume | 188 |
| Q28114992 | A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum |
| Q30884165 | A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. |
| Q47761403 | A novel mechanism of anti-T-lymphocyte globulin mediated by fractalkine in renal ischemia-reperfusion injury in rats |
| Q35879006 | Absence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model |
| Q83917871 | Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation |
| Q33828033 | Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis |
| Q51778397 | An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q39767301 | Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines |
| Q50949437 | Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis. |
| Q28574502 | Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil clearance |
| Q34186648 | Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo |
| Q27631819 | CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure |
| Q47657404 | Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1. |
| Q59353572 | Chemokine Subversion by Human Herpesviruses |
| Q43634198 | Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat. |
| Q48691634 | Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice |
| Q74481121 | Chemokine receptors |
| Q58246532 | Chemokines and atherosclerosis |
| Q34306643 | Chemokines and viral diseases of the central nervous system |
| Q33749233 | Chemokines as therapeutic targets in renal inflammation |
| Q40067378 | Chemokines encoded by herpesviruses |
| Q34253917 | Chemokines in renal diseases |
| Q33632729 | Cytotoxic T lymphocytes, chemokines and antiviral immunity |
| Q33622543 | Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency |
| Q88540308 | Different effects of global osteopontin and macrophage osteopontin in glomerular injury |
| Q22253325 | Differential activation of CC chemokine receptors by AOP-RANTES |
| Q51218774 | Elevated serum interferon γ-inducible protein-10 in women with polycystic ovary syndrome. |
| Q47897154 | Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. |
| Q33824614 | Evasion and exploitation of chemokines by viruses |
| Q36409618 | Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma |
| Q50856307 | Expression of CX3CL1 and its receptor, CX3CR1, in the development of periapical lesions. |
| Q43683982 | FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines |
| Q77136106 | Fractalkine and vascular injury |
| Q28142813 | Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation |
| Q74242399 | Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis |
| Q22253856 | Fractalkine-mediated endothelial cell injury by NK cells |
| Q37670253 | Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential |
| Q42964042 | Fractalkine: a novel cardiac chemokine? |
| Q53523468 | Fractalkine: an important candidate for directing periglomerular leukocyte accumulation in irradiated mouse kidneys. |
| Q36249009 | Fugetaxis: active movement of leukocytes away from a chemokinetic agent. |
| Q45867749 | Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity. |
| Q48263003 | Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus |
| Q81776040 | Glomerulonephritis |
| Q43012842 | Higher peripheral neutrophil and monocyte counts are independent indicators of the presence and severity of proteinuria in apparently normal adults |
| Q34022959 | Host-related immunomodulators encoded by poxviruses and herpesviruses |
| Q39594830 | Human herpesvirus 6 open reading frame U83 encodes a functional chemokine |
| Q33813244 | Human herpesvirus 8-encoded cytokines |
| Q37123224 | IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting |
| Q35845313 | Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q80212464 | Immune evasion by Kaposi's sarcoma-associated herpesvirus |
| Q37307209 | Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis |
| Q35757157 | Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
| Q41534964 | Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis |
| Q28296088 | Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3 |
| Q29394711 | Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? |
| Q44496925 | Kinetics of chemokines and their receptors in mercuric chloride-induced tubulointerstitial lesions in brown Norway rats |
| Q46181399 | Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo |
| Q36972471 | Leukocytes in glomerular injury |
| Q41630185 | Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury |
| Q41939544 | Macrophage trafficking as key mediator of adenine-induced kidney injury. |
| Q33826596 | Modulating chemokines: more lessons from viruses |
| Q35801076 | Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies |
| Q28584356 | Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
| Q34390819 | Molecular machinations: chemokine signals in host-pathogen interactions |
| Q34234132 | Molecular piracy of Kaposi's sarcoma associated herpesvirus |
| Q28567754 | Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis |
| Q39403089 | Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II. |
| Q35174136 | Pathogenesis of Kaposi's sarcoma |
| Q40795559 | Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade |
| Q80501260 | Potential role of fractalkine receptor expression in human renal fibrogenesis |
| Q37651901 | Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy |
| Q35624562 | Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation |
| Q33942036 | Role of chemokines in inflammation and immunoregulation |
| Q35022576 | Slit proteins, potential endogenous modulators of inflammation |
| Q47431326 | Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis |
| Q42380472 | Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation |
| Q38294927 | Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways. |
| Q83265995 | Synergistic induction of CX3CL1 by interleukin-1β and interferon-γ in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways |
| Q28349698 | Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection |
| Q34996665 | The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. |
| Q42164450 | The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor. |
| Q34605505 | The molecular pathology of Kaposi's sarcoma-associated herpesvirus |
| Q36676173 | The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment |
| Q34961799 | The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors |
| Q35149350 | The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation |
| Q36752499 | Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer |
| Q35055369 | Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice |
| Q33933260 | Viral exploitation and subversion of the immune system through chemokine mimicry |
| Q35082163 | Viral leads for chemokine-modulatory drugs. |
| Q42709776 | Viral macrophage inflammatory protein-II improves acute rejection in allogeneic rat kidney transplants |
| Q28201716 | Viral mimicry of cytokines, chemokines and their receptors |
| Q34225991 | Virally encoded 7TM receptors |
| Q34451942 | Virokines: novel immunomodulatory agents |
Search more.